Ledger.Open graph →
SEC Form D · filed April 28, 2023

Allarity Therapeutics, Inc

Offering
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David A. Roth · Boston, MADirectorGerald G. Mclaughlin · Boston, MADirectorJoan G. Brown · Boston, MAExecMarie A. Foegh · Boston, MAExecThomas A. Jensen · Boston, MAExec · DirectorSteen A. Knudsen · Boston, MAExecJames G. Cullem · Boston, MAExec · DirectorRyan Black · FLORENCE, SCExecJulian Fletcher · Grand Cayman, Cayman IslandsExecPatrick A. Rentz · Los Angeles, CAExec · DirectorGeoffrey L. Butler · New York, NYDirectorAustin Willis · Coconut Creek, FLExecSachin S. Bavishi · SAN FRANCISCO, CADirectorNicolin R. Decker · Broken Arrow, OKExec · DirectorMichael Stocker · Vancouver, British Columbia, CanadaExec · DirectorNeil Branda · Vancouver, British Columbia, CanadaDirectorDirk Lange · Vancouver, British Columbia, CanadaExec · DirectorBrent Hunter · Vancouver, British Columbia, CanadaExecDouglas Frankiw · Vancouver, British Columbia, CanadaDirectorGiovanni Y. Patuzzo · New York, NYExecSimon O. Trautmann · Doha, S3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗